G01N 33/566
Using specific carrier or receptor proteins as ligand binding reagents where possible
Official title: using specific carrier or receptor proteins as ligand binding reagents {where possible specific carrier or receptor proteins are classified with their target compounds}
G01N33/566 (Using specific carrier or receptor proteins as ligand binding reagents where possible) appears on 1,913 US grants and 3,055 published applications in this corpus.
Search patents in G01N- Granted patents
- 1,913
- Published applications
- 3,055
- Assignees
- 1,253
- Inventors
- 5,398
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 7 | 0 |
| 1988 | 1 | 0 |
| 1989 | 9 | 0 |
| 1990 | 9 | 0 |
| 1991 | 9 | 0 |
| 1992 | 7 | 0 |
| 1993 | 12 | 0 |
| 1994 | 18 | 0 |
| 1995 | 15 | 0 |
| 1996 | 16 | 0 |
| 1997 | 24 | 0 |
| 1998 | 67 | 0 |
| 1999 | 49 | 0 |
| 2000 | 29 | 0 |
| 2001 | 35 | 13 |
| 2002 | 41 | 98 |
| 2003 | 28 | 384 |
| 2004 | 43 | 151 |
| 2005 | 37 | 134 |
| 2006 | 56 | 148 |
| 2007 | 71 | 142 |
| 2008 | 86 | 105 |
| 2009 | 79 | 151 |
| 2010 | 76 | 140 |
| 2011 | 84 | 114 |
| 2012 | 72 | 123 |
| 2013 | 78 | 114 |
| 2014 | 78 | 143 |
| 2015 | 82 | 105 |
| 2016 | 69 | 139 |
| 2017 | 95 | 115 |
| 2018 | 72 | 145 |
| 2019 | 86 | 128 |
| 2020 | 85 | 102 |
| 2021 | 70 | 85 |
| 2022 | 69 | 85 |
| 2023 | 39 | 75 |
| 2024 | 43 | 43 |
| 2025 | 32 | 50 |
| 2026 | 31 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Pharmaceutical composition for lowering blood cholesterol, preventing or treating cardiovascular diseases and reducing inflammation25 Aug 2026US 12,715,899 B2Seoul National University Hospital
- Multimeric proteins for detecting a carbohydrate and/or treating a siglec-mediated disorder25 Aug 2026US 12,715,903 B2Palleon Pharmaceuticals Inc.
- Methods for determining differences in alpha-4 integrin activity by correlating differences in sVCAM and/or sMAdCAM levels25 Aug 2026US 12,716,899 B2Biogen MA Inc.
- Methods for making cleaning compositions and detecting soils18 Aug 2026US 12,710,371 B2The Procter & Gamble Company
- Composition for cancer diagnosis18 Aug 2026US 12,710,425 B2Acurasysbio Co., Ltd.
- Method for producing cells for measuring activity of sensor protein1 Oct 2026US 2026/0297510 A1Sumitomo Chemical Company, Limited
- Chimeric receptor for use in whole-cell sensors for detecting analytes of interest27 Aug 2026US 2026/0251653 A1Centre National de la Recherche Scientifique (CNRS)
- Method for evaluating receptor-type tyrosine kinase activity20 Aug 2026US 2026/0243779 A1Riken
- Electrochemical analysis kit, electrochemical analysis system, and electrochemical analysis method13 Aug 2026US 2026/0235545 A1Immunosens Co., Ltd.
- Enhancement of synaptogenesis by activation of teneurins6 Aug 2026US 2026/0224661 A1The Board of Trustees of the Leland Stanford Junior University
Most cited
By later US patents
- Use of modified tethers in screening compound libraries330US 5,958,703 AGlaxo Group Limited · 1999
- Use of retentate chromatography to generate difference maps229US 6,225,047 B1Ciphergen Biosystems, Inc. · 2001
- Indicator compounds, devices comprising indicator compounds, and methods of making and using the same164US 11,951,186 B2Willow Laboratories, Inc. · 2024
- Novel receptors for efficient determination of ligands and their antagonists or agonists158US 4,859,609 AGenentech, Inc. · 1989
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009